CN116948939A - Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium - Google Patents
Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium Download PDFInfo
- Publication number
- CN116948939A CN116948939A CN202311197586.0A CN202311197586A CN116948939A CN 116948939 A CN116948939 A CN 116948939A CN 202311197586 A CN202311197586 A CN 202311197586A CN 116948939 A CN116948939 A CN 116948939A
- Authority
- CN
- China
- Prior art keywords
- medium
- enrichment
- cucl
- culture medium
- ycfa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001963 growth medium Substances 0.000 title claims abstract description 40
- 230000002550 fecal effect Effects 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 17
- 239000002609 medium Substances 0.000 claims abstract description 50
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims abstract description 38
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims abstract description 38
- 241000894007 species Species 0.000 claims abstract description 22
- 238000000926 separation method Methods 0.000 claims abstract description 10
- 238000012545 processing Methods 0.000 claims abstract description 6
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 claims abstract 5
- 239000000203 mixture Substances 0.000 claims description 40
- 241000194033 Enterococcus Species 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 7
- 241000742045 Paraclostridium Species 0.000 claims description 6
- 244000039328 opportunistic pathogen Species 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 244000005700 microbiome Species 0.000 abstract description 30
- 230000000968 intestinal effect Effects 0.000 abstract description 6
- 241000233866 Fungi Species 0.000 abstract description 4
- 238000002955 isolation Methods 0.000 abstract description 4
- 239000006041 probiotic Substances 0.000 abstract description 2
- 235000018291 probiotics Nutrition 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 43
- 238000009835 boiling Methods 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- 239000000306 component Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000010411 cooking Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 150000001945 cysteines Chemical class 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- 241000607764 Shigella dysenteriae Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 229940007046 shigella dysenteriae Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000194031 Enterococcus faecium Species 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 239000007169 ycfa-medium Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000580513 Citrobacter braakii Species 0.000 description 2
- 241000186542 Clostridium baratii Species 0.000 description 2
- 241000186528 Clostridium tertium Species 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- 241001468179 Enterococcus avium Species 0.000 description 2
- 241000520130 Enterococcus durans Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000194030 Enterococcus gallinarum Species 0.000 description 2
- 241000194029 Enterococcus hirae Species 0.000 description 2
- 241000192016 Finegoldia magna Species 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241001607075 Peptoniphilus tyrrelliae Species 0.000 description 2
- 241000896231 Phocaeicola Species 0.000 description 2
- 241000607760 Shigella sonnei Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 241000193450 [Clostridium] symbiosum Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000011177 media preparation Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229940115939 shigella sonnei Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- -1 Acyl homoserine lactone Chemical compound 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000319947 Anaerotignum lactatifermentans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108700029181 Bacteria lipase activator Proteins 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241000927722 Bacteroides kribbi Species 0.000 description 1
- 241001122266 Bacteroides nordii Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 241000606219 Bacteroides uniformis Species 0.000 description 1
- 241000008904 Betacoronavirus Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000206827 Bittarella massiliensis Species 0.000 description 1
- 241001464894 Blautia producta Species 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241001464974 Cutibacterium avidum Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241001657508 Eggerthella lenta Species 0.000 description 1
- 241001522957 Enterococcus casseliflavus Species 0.000 description 1
- 241000320082 Enterococcus gilvus Species 0.000 description 1
- 241000520134 Enterococcus mundtii Species 0.000 description 1
- 241001235138 Enterococcus raffinosus Species 0.000 description 1
- 241001026958 Enterococcus thailandicus Species 0.000 description 1
- 241000962428 Enterococcus xiangfangensis Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- 241000520740 Eubacterium callanderi Species 0.000 description 1
- 241001134569 Flavonifractor plautii Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000037075 Intestinibacter bartlettii Species 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000193465 Paeniclostridium sordellii Species 0.000 description 1
- 241000606210 Parabacteroides distasonis Species 0.000 description 1
- 241000204306 Parabacteroides merdae Species 0.000 description 1
- 241001464878 Peptoniphilus indolicus Species 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 241000190045 Ruthenibacterium lactatiformans Species 0.000 description 1
- 241000194008 Streptococcus anginosus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the field of microorganism separation culture, and particularly relates to a method and a culture medium for improving the bacterial diversity of a fecal sample and application thereof. The method for improving the fungus picking diversity of the fecal sample provided by the invention comprises the following steps: sample processing, enrichment culture, colony isolation, wherein the enrichment culture medium comprises YCFA synthetic medium, cysteine salt, TE141, VFA-mix and high-concentration CuCl 2 Or a hydrate thereof. The enrichment medium provided by the invention can separate more species of culturable microorganisms, and remarkably improves the culturable microorganisms in the fecal sampleThe diversity can provide support for the screening of novel intestinal probiotics.
Description
Technical Field
The invention belongs to the field of microorganism separation culture, and particularly relates to a method and a culture medium for improving the bacterial diversity of a fecal sample and application thereof.
Background
Microorganisms are the most widely distributed, most abundant species and the largest biomass life forms on earth. Human beings have found microorganisms for over two hundred years, but only for over a hundred years. To date, human cognition and development utilizes less than 1% of the total species of microorganisms, and less than few microorganisms can be cultivated. The development and utilization of the culturable microorganisms can develop into an emerging industry or promote the improvement and upgrade of the traditional industry: currently advanced gene editing techniques, such as CRISPR techniques, were first discovered in microbial cells; the large-scale microorganism manufacturing industry, such as microbiological pharmacy, microbiological fermentation, microbiological transformation and the like, relates to the economic field, and is a large industry closely related to people's life, industrial and agricultural production, national defense construction and the like.
Intestinal microorganisms are important "organs" of the human body, and are closely related to various physiological functions such as immunity, nutrition, metabolism and the like. The complex relationship between intestinal microorganisms and human health has been elucidated using macrogenomic sequencing techniques, but without bacterial isolates, the intrinsic mechanism by which specific bacteria act in the intestinal tract cannot be clarified, thereby further compromising the discovery of "dark matter" in the intestinal tract. The acquisition of the culturable microorganism provides a bacterial sample for deeply researching bacterial phenotype and gene function, and also provides data support for screening novel probiotics in intestinal tracts.
The technology of plate streaking is used as a traditional microorganism separation culture means, and at present, isolated intestinal microorganisms are mostly subjected to plate streaking by using a YCFA culture medium to obtain pure culture strains, and according to researches, the YCFA culture medium can provide 70% of substances required by the growth of human intestinal microorganisms. However, human intestinal culturable microorganisms isolated using only YCFA medium are limited, and some species that grow rapidly and are easy to culture (e.g., enterococcus, E.coli, P.aeruginosa, etc.) can quickly occupy most of the space of the culture plate, making it more difficult to isolate bacteria of other species. The diversity of microorganism species obtained under the same picking workload is lower. Therefore, it is necessary to expand the resources of the microorganisms that can be cultivated by means of improving the medium components and optimizing the cultivation conditions.
The optimization of the culture medium is mainly to adjust the components of the culture medium, and certain special substances are added into the conventional culture medium, for example, an inhibitor (antibiotics, ethanol and metabolic inhibitor) can be added to inhibit the growth of certain non-target bacteria, a signal molecule, namely, cyclic adenosine monophosphate (Cyclic Adenosine Monophosphate, cAMP) and Acyl homoserine lactone (Acyl-Homoserine Lactones, AHL) can be added to improve the microorganism culture efficiency, and certain growth factors (such as amino acids, vitamins and metal ions) can be added to promote the growth and metabolism of microorganisms.
The metal ions are used as important components in the culture medium and participate in various biochemical reactions in cells, and can be used as component parts of enzymes and participate in the metabolic processes of microorganisms. Li Lanxiao et al (study of the influence of Metal ions and growth factors on riboflavin fermentation) report CuSO 4 ·5H 2 O can promote the growth of bacillus subtilis and increase the yield of riboflavin. However, the use of metal ions in the prior art for the purpose of promoting the growth of certain microorganisms has not been used to increase the diversity of culturable microorganisms in fecal samples.
Disclosure of Invention
To solve the unmet practical needs of the prior art, the first aspect of the invention provides a method for improving the diversity of fecal sample picking bacteria.
The specific scheme is as follows:
a method for improving the diversity of fecal sample picking bacteria, comprising:
(1) Sample processing;
(2) Enrichment culture;
(3) Separating bacterial colonies;
wherein: the enrichment medium of step (2), comprising per 1L of medium the following components: 16.5-20.3 g YCFA synthetic culture medium, 0.9-1.1 g cysteine salt, 9-11 mL TE141, 2.9-3.5 mL VFA-mix, characterized in that CuCl is added into the enrichment culture medium 2 Or a hydrate thereof, in CuCl 2 The content of the composition is 140-180 mg/L.
The second aspect of the invention provides CuCl 2 Or a hydrate thereof, in the preparation of an enrichment medium for increasing the diversity of the stool sample, each 1L of medium comprising the following components: 16.5-20.3 g of YCFA synthetic medium, 0.9-1.1 g of cysteine salt, 9-11 mL of TE141 and 2.9-3.5 mL of VFA-mix.
In a third aspect of the invention, an enrichment medium for increasing the diversity of fecal sample picking bacteria is provided, each 1L of the medium comprising the following components: 16.5-20.3 g of YCFA synthetic medium, 0.9-1.1 g of cysteine salt, 9-11 mL of TE141 and 2.9-3.5 mL of VFA-mix.
In some embodiments, cuCl is added to the enrichment medium 2 Or a hydrate thereof.
In some embodiments, in CuCl 2 Based on the amount of CuCl added to the enrichment medium 2 The content is 140-180 mg/L.
In some embodiments, in CuCl 2 Based on the amount of CuCl added to the enrichment medium 2 The content is 160 mg/L.
In some embodiments, the enrichment medium can reduce the segregation duty cycle of pathogenic and/or opportunistic pathogens in the fecal sample.
In some embodiments, the enrichment medium may reduce the amount of a sample of fecal material selected from the group consisting of enterococcus tenuiosusEnterococcus durans)、Paraclostridium dentumBacillus dysenteriaeShigella dysenteriae) Enterococcus faeciumEnterococcus faecium) The separation duty cycle of any one of the species.
In some embodiments, each 1L medium comprises the following components: 18.44 g YCFA synthetic medium, 160 mg CuCl 2 (in CuCl) 2 Meter), 1 g cysteine salt, 10.00 mL of te141, 3.2 mL of VFA-mix.
The invention has the following beneficial effects:
(1) The improved culture medium provided by the invention can effectively reduce dominant species in the fecal sample on the separation plateEnterococcus durans(enterococcus tenaciosus),Paraclostridium dentum、Shigella dysenteriae(shigella dysenteriae),Enterococcus faeciumThe ratio of species such as (enterococcus faecium) is reduced by about 10%, the diversity of the culturable strains of the faeces sample is improved, and 33 species of culturable strains are separated on the premise of less colony count compared with the control group.
(2) The culture medium used in the technical proposal of the invention has simple components, namely, the conventional culture medium is added with CuCl 2 Or a hydrate thereof; the whole experimental process is simple, convenient and easy to get up.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below. It is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments, and that all other embodiments obtained by a person skilled in the art without making creative efforts based on the embodiments in the present invention shall fall within the protection scope of the present invention.
"diversity" refers to the abundance of a microbial species in a sample. The higher the diversity means the greater the number of species of microorganism in the sample; the lower the diversity means that the fewer the number of species of microorganism in the sample.
"separation ratio" refers to the ratio of the total number of microorganisms of a certain species separated from a sample to the number of all communities separated from the sample.
CuCl of the invention 2 Is an important component for increasing the diversity of the fecal sample, and can be added in any form, such as anhydrate or hydrate, the water content of the hydrate can be any value, the water content does not affect the final effect, and the common CuCl is adopted in one embodiment of the invention 2 ·2H 2 O。
The method for improving the fungus picking diversity of the fecal sample comprises the following steps:
(1) Sample processing;
(2) Enrichment culture;
(3) Separating bacterial colonies;
wherein: adding CuCl into the enrichment medium in the step (2) 2 Or a hydrate thereof.
The sample treatment in step (1) is to treat the collected fecal sample, which are conventional in the art, including sample weighing, addition of protective agents, shaking, centrifugation, and liquid sample acquisition.
The enrichment culture in the step (2) is to add the sample into an enrichment culture medium and culture under proper conditions (such as 37 ℃ C., anaerobic). Under the condition of no special treatment, the bacteria cultured in the step (2) are mainly dominant bacteria existing in the sample. In order to increase the diversity of the obtained strains, the whole fungus picking process can only be repeated for a plurality of times. Even so, due to the dominanceThe competition of seeds, the growth of strains with small content is inhibited, and finally, the strains are difficult to pick. The invention adds CuCl 2 Or the hydrate thereof can reduce the ratio of a plurality of dominant species and improve the species diversity of the final selected bacteria.
In some embodiments, in CuCl 2 Meter, cuCl 2 Or the addition amount of the hydrate is 140-180 mg/L. Within this range, inhibition of dominant species and normal growth of less-than-species are better balanced, in one particular case, in CuCl 2 The addition amount is 160 mg/L.
The colony isolation in the step (3) is to take and dilute the enriched sample in the step (2) and then culture the diluted enriched sample again so as to obtain a pure culture of single colony.
Based on the discovery of the method, the invention also provides CuCl 2 Or the hydrate thereof, in the preparation of an enrichment medium for improving the diversity of fecal sample picking bacteria.
Based on the findings of the foregoing methods, the present invention further provides an enrichment medium for improving the diversity of fecal sample picking bacteria, the medium comprising CuCl 2 Or a hydrate thereof.
The preparation methods of the culture medium, the reagent, etc. used in the following examples are as follows:
YCFA+160 mg/L CuCl 2 experiment medium: weighing the corresponding amount of the reagent according to the formula dosage of the reagent in the table 1, adding the corresponding amount of boiled pure water into a triangular flask, and stirring and dissolving by a glass rod; boiling, adding two boiling reagents, adjusting pH to 7.0-7.5, and opening Hengalit device to make culture medium in N 2 Boiling again under protection, blowing for about 20 min, and collecting the residue in N 2 Is divided into N parts under protection 2 In the deoxidized anaerobic bottle, the liquid split charging height is not more than 2/3 of the height of the anaerobic bottle; and (5) partially packaging 10-mL into anaerobic tubes, capping plugs, attaching culture medium label paper, and sterilizing at 121 ℃ under moist heat for 15-20 min. Agar powder was added in an amount of 1.5% (mass/volume ratio, 15 g/L) to prepare a solid medium.
TABLE 1 YCFA+160 mg/L CuCl 2 Preparation of experimental culture medium
Reagent name | Formulation dosage (1L) | Remarks |
YCFA synthetic culture medium | 18.44 g | One-boiling |
CuCl 2 ·2H 2 O | 0.20 g | One-boiling |
Cysteine salts | 1.00 g | Two-stage cooking |
TE141 | 10.00 mL | Two-stage cooking |
VFA-mix | 3.2 mL | Two-stage cooking |
Note that: YCFA synthetic medium, manufacturer: qingdao sea blogs, goods number: HB9212
YCFA+160 mg/L CuSO 4 Control medium: formulated according to the formulation amounts of the reagents in Table 2, the procedure is referenced YCFA+160 mg/L CuCl 2 Experimental medium preparation step.
TABLE 2 YCFA+160 mg/L CuSO 4 Control Medium formulation
Reagent name | Formulation dosage (1L) | Remarks |
YCFA synthetic culture medium | 18.44 g | One-boiling |
CuSO 4 ·5H 2 O | 0.25 g | One-boiling |
Cysteine salts | 1.00 g | Two-stage cooking |
TE141 | 10.00 mL | Two-stage cooking |
VFA-mix | 3.2 mL | Two-stage cooking |
YCFA control medium: formulated according to the formulation amounts of the reagents in Table 3, the procedure is referenced YCFA+160 mg/L CuCl 2 Experimental medium preparation step.
TABLE 3 YCFA control Medium formulation
Reagent name | Formulation dosage (1L) | Remarks |
YCFA synthetic culture medium | 18.44 g | One-boiling |
Cysteine salts | 1.00 g | Two-stage cooking |
TE141 | 10.00 mL | Two-stage cooking |
VFA-mix | 3.2 mL | Two-stage cooking |
VFA-mix: acetic acid 27 mL, propionic acid 9 mL, n-valeric acid 3 mL, isobutyric acid 3 mL and butyric acid 3 mL are measured and mixed uniformly for later use.
TE141: the reagents were weighed according to the amounts in the formulations of Table 4. In the first step, nitrilotriacetic acid (Nnitrilotriacetic acid) is added into 800 mL pure water, the pH is regulated to 7.0, after the mixture is stirred until the mixture is clarified, water is continuously added to 1000 mL, and finally the pH is regulated to 6.5. The other components were added sequentially in the order listed, each step was stirred until clear, and if clear was not achieved for a long period of time, the pH was adjusted to 6.5. Weighing Na 2 SeO 3 ·5H 2 O0.12508 g, adding 12.5. 12.5 mL pure water, dissolving completely to obtain Na 2 SeO 3 ·5H 2 And using O mother liquor. Weighing Na 2 WO 4 ·2H 2 O0.14735 g, adding 14.7. 14.7 mL pure water, dissolving completely to obtain Na 2 WO 4 ·2H 2 And using O mother liquor. Finally, the clarified TE141 is packaged and labeled, and the product is placed and stored at room temperature.
Table 4 formulation of te141
Reagent name | Formulation dosage (1L) |
Nnitrilotriacetic acid | 1.50324 g |
MgSO 4 ·7H 2 O | 3.00384 g |
MnSO 4 ·H 2 O | 0.50442 g |
NaCl | 1.00415 g |
FeSO 4 ·7H 2 O | 0.10378 g |
CoSO 4 ·7H 2 O | 0.18171 g |
CaCl·2H 2 O | 0.11388 g |
CuSO 4 ·5H 2 O | 0.01331 g |
ZnSO 4 ·7H 2 O | 0.18426 g |
KAI(SO4) 2 ·12H 2 O | 0.02003 g |
H 2 BO 3 | 0.01391 g |
Na 2 MO 4 ·2H 2 O | 0.01096 g |
NiCL·6H 2 O | 0.0339 g |
Na 2 SeO 3 ·5H 2 O | 0.03 mL mother liquor |
Na 2 WO 4 ·2H 2 O | 0.04 mL mother liquor |
NaOH solution | Adjusting pH |
HCl solution | Adjusting pH |
Preparing a flat plate: YCFA+160 mg/LCuCl 2 Solid medium, YCFA+160 mg/LCuSO 4 The solid culture medium and the YCFA solid culture medium are heated at 104 ℃ for 25-30 min respectively, and then are dissolved, and are placed in a water bath kettle at 50 ℃. Mix sugar was filtered through a 0.22 μm filter and added to the medium, 9.6 ml Mix sugar was added per 360. 360 ml medium, the plates were poured into a biosafety cabinet, air dried for 20 minutes, and transferred to an anaerobic glove box overnight for deoxygenation.
Mix sugar: the reagents were weighed according to the amounts in the formulations of Table 5. Mixing the boiled deoxidized components in proportion, proportionally metering to a proper volume, introducing nitrogen to deoxidize for 30 min, packaging and sealing, and sterilizing at 115 ℃ for 20 min under high pressure. 0.5% Vitamin K1 mother liquor: 0.1 mlailamin K1+20ml 95% ethanol. 2 mg/mL of a Heamin mother liquor: 200 mg of Heamin+4 mL of 1M NaOH was fixed to a volume of 100 mL. The filter sterilized components were added in proportion, added to the sterilized sugar solution using a syringe and needle filter, and the filtration was performed in an anaerobic glove box. And 4. After the filtration is completed, the mixture is stored at a temperature of 4 ℃ in a dark place.
TABLE 5 preparation of Mix sugar
Reagent name | Conversion amount | Remarks |
Glucose(50%) | 5.00 g | Boiling deoxidization |
Maltose(10%) | 0.50 g | Boiling deoxidization |
Cellobiose(10%) | 0.50 g | Boiling deoxidization |
Pure water | Constant volume 20 mL | Boiling deoxidization |
10·V141 | 1 mL | Filter sterilization |
Vitamin K1 | 0.13 mL | Filter sterilization |
Heamin | 3.27 mL | Filter sterilization |
Totalizing | 24.4 mL |
10.v 141: after all the components in Table 6 were dissolved, a 0.22 μm filter was used for sterilization and sealed for use.
TABLE 6 preparation of 10V 141
Reagent name | Dosage of the formula |
Biotin | 20.00 mg |
Folic acid | 20.00 mg |
Pyridoxine-HCl | 100.00 mg |
Thiamine-HCl·2H 2 O | 50.00 mg |
Riboflavin | 50.00 mg |
Nicotinic acid | 50.00 mg |
Ca-pantothenate | 50.00 mg |
Vitamin B 12 | 1.00 mg |
p-Aminobenzoic acid | 50.00 mg |
Lipoic acid | 50.00 mg |
Purified water | 1000.00 mL |
And (3) a protective agent: formulated according to the formulation amounts of the reagents in Table 7, the procedure is referenced YCFA+160mg/L CuCl 2 And (5) preparing an experiment culture medium.
Table 7 protectant formulation
Reagent name | Formulation dosage (1L) | Remarks |
Na 2 HPO 4 ·12H 2 O | 3.85 g | One-boiling |
KH 2 PO 4 | 0.27 g | One-boiling |
NaCl | 8.00 g | One-boiling |
Glycerol | 200 mL | One-boiling |
Cysteine salts | 1.00 g | Two-stage cooking |
Resazurin (L.) Kuntze | 1 mL | 0.1% aqueous solution |
Lysate: mixing pure formic acid and pure acetonitrile according to the proportion of 4:3, and uniformly mixing.
Matrix liquid: uniformly mixing 5% trifluoroacetic acid (spectrum level) and acetonitrile according to a ratio of 1:1 to obtain a matrix solvent; alpha-cyano-4-hydroxy cinnamic acid is added into a matrix solvent to prepare a matrix solution with the concentration of 10 mg/ml.
Example 1 sample processing, enrichment culture and separation
(1) Sample processing
a. Weighing and recording color, character and other information after the original fecal sample arrives at a laboratory;
b. taking 1 branch of clean 50 mL centrifuge tubes, and adding 6-7 sterilized and dried glass beads into the centrifuge tubes;
c. picking 0.5-1 g of sample in a 50 mL anaerobic sample tube in an anaerobic glove box, adding 10 times of volume protective agent, covering a spiral cover, after rotating and oscillating for 5 minutes, subpackaging a Pasteur pipette with about 1 mL/spiral cap tube, and pasting corresponding labels on each tube;
d. putting the split-packed samples into a 9*9 freezing box, then putting into a music buckle box, putting into 2 anaerobic deoxidizing bags, and preserving at a low temperature of minus 80 ℃;
(2) Enrichment culture
Randomly picking up a frozen sample at the temperature of minus 80 ℃, thawing in an anaerobic glove box, respectively taking 0.1 mL sample, adding the sample into an anaerobic tube of 10 mL for enrichment, and adding 160 mg/L CuCl 2 The YCFA medium of (2) was set as an experimental group, the YCFA medium without copper ions was set as a control group 1, and 160 mg/L CuSO was added 4 Is set as control group 2. Anaerobic culture was performed at 37℃for 14 days with shaking of the anaerobic tube every 2-3 days in the middle.
(3) Colony isolation
a. Sample coating: taking enriched samples of 0.5 mL each in 4.5 ml diluted anaerobic PBS, mixing uniformly and recording as 10 -1 Gradient, then sequentially carrying out 10-time gradient dilution; take 10 -3 To 10 -4 Diluting gradient liquid 100 μl each, coating onto corresponding plate, placing coated plate in a music buckle box, adding deoxidizingBags, anaerobic culture for 4-5 days.
b. Picking a bacterial colony: filtering and sterilizing Mix sugar, adding YCFA+160 mg/L CuCl respectively 2 Liquid culture medium, YCFA+160 mg/L CuSO 4 Liquid medium and YCFA liquid medium (9.6 ml Mix sugar is added into 360. 360 ml medium), and then the culture medium is respectively split into 384 plates 1 and 2 (80 mu L per well); according to different properties of bacterial colony such as morphology, size, color and dryness, bacterial colony is picked into 384-well plate 1, 10 mu L of liquid is inoculated into 384-well plate 2 corresponding hole sites after blowing and mixing uniformly, and 96 bacterial colonies are picked for each sample.
EXAMPLE 2 colony identification
(1) Autof MS2000 weight reduction
Taking out 384 plates 2 of example 1, centrifuging at 5000 rpm for 10 min, discarding the supernatant, washing with ultra pure water (80. Mu.L/well), centrifuging at 5000 rpm for 10 min, discarding the supernatant, and repeating the above steps once; adding 10 mu L/hole lysate into 384-well plate, mixing, blowing, taking 1 mu L supernatant to spot target, air drying at room temperature, and spot-adding 1 mu L matrix solution; performing mass spectrum identification after airing at room temperature; and (3) carrying out cluster analysis according to the protein patterns of the bacterial colonies, randomly selecting a hole site from 5 identical patterns, picking the hole site to a new 96-well plate 1 and 2 with corresponding liquid culture medium, culturing for 2-3 days at 37 ℃, and then carrying out PCR sequencing by using the 96-well plate 1.
(2) PCR sequencing
Sample washing before PCR: centrifuging 96-well plate 1 at 5300 rpm for 10 min, and discarding supernatant; adding 30-100 μl of 1×TE resuspended thallus per well according to fungus concentration, centrifuging at 5300 rpm for 10 min, and discarding supernatant; the resuspended cells were stored at-80℃overnight.
PCR detection: taking out the frozen overnight bacterial liquid plate, breaking the walls by microwaves for 3-4 times, each time for 1 minute and 30 seconds, and placing the bacterial liquid plate on ice for complete cooling after each time of microwave heating and then carrying out the next microwave operation; the PCR reaction system was prepared according to the sample amount (see Table 8). The 96-well PCR plate was placed on a PCR instrument and the amplification procedure was set: 98℃for 5 min,98℃for 10 s,58℃for 10 s,72℃for 20 s,30 cycles, 72℃for 2 min,4℃for the end of amplification; the PCR product was sent to sequencing systems, inc. of Programme technologies for sequencing.
TABLE 8 PCR reaction System
Composition of the components | Volume of |
2×T5 Supr PCR Mix(Colony) | 12.5 μL |
5×Enhacer Buffer | 5 μL |
27-F | 1 μL |
1492-R | 1 μL |
PCR water (sterilized ultrapure water) | 4.5 μL |
DNA template | 1 μL |
c. Analysis of results: and uploading the 16S sequence fed back by the sequencing company to a refseq library of NCBI for sequence comparison, and obtaining the Latin name corresponding to the sequence.
TABLE 9 isolation and identification of microorganisms in stool samples of experimental and control groups
Experimental group | Experiment Group of | Experimental group | Control group 1 | Control group 1 | Control group 1 | Control group 2 | Control group 2 | Control group 2 |
Species | Quantity of | Split duty cycle (%) | Species | Quantity of | Split duty cycle (%) | Species | Quantity of | Split duty cycle (%) |
Enterococcus durans | 28 | 11.38 | Enterococcus durans | 63 | 19.27 | Peptoniphilus tyrrelliae | 19 | 26.76 |
Clostridium butyricum | 23 | 9.35 | Paraclostridium dentum | 62 | 18.96 | Enterococcus mundtii | 17 | 23.94 |
Enterococcus faecalis | 19 | 7.72 | Shigella dysenteriae | 51 | 15.60 | Peptoniphilus indolicus | 10 | 14.08 |
Enterococcus avium | 17 | 6.91 | Enterococcus faecium | 41 | 12.54 | Finegoldia magna | 9 | 12.68 |
Shigella dysenteriae | 16 | 6.50 | Enterococcus innesii | 30 | 9.17 | Ruthenibacterium lactatiformans | 7 | 9.86 |
Shigella sonnei | 9 | 3.66 | Shigella sonnei | 20 | 6.12 | Clostridium lactatifermentans | 3 | 4.23 |
Enterococcus innesii | 9 | 3.66 | Enterococcus gallinarum | 17 | 5.20 | Bacillus licheniformis | 2 | 2.82 |
Bacteroides uniformis | 8 | 3.25 | Clostridium baratii | 14 | 4.28 | Enterococcus casseliflavus | 2 | 2.82 |
Finegoldia magna | 7 | 2.85 | Enterococcus avium | 11 | 3.36 | Enterococcus faecium | 1 | 1.41 |
Phocaeicola vulgatus | 7 | 2.85 | Clostridium tertium | 6 | 1.83 | Clostridium sordellii | 1 | 1.41 |
Bacteroides thetaiotaomicron | 6 | 2.44 | Enterococcus faecalis | 5 | 1.53 | |||
Thomasclavelia ramosa | 6 | 2.44 | Citrobacter braakii | 5 | 1.53 | |||
Enterococcus hirae | 5 | 2.03 | [Clostridium] symbiosum | 1 | 0.31 | |||
Clostridium baratii | 5 | 2.03 | Enterococcus hirae | 1 | 0.31 | |||
Parabacteroides distasonis | 5 | 2.03 | ||||||
Eubacterium maltosivorans | 5 | 2.03 | ||||||
Enterococcus gilvus | 5 | 2.03 | ||||||
Enterococcus xiangfangensis | 4 | 1.63 | ||||||
Paraclostridium dentum | 4 | 1.63 | ||||||
Intestinibacter bartlettii | 4 | 1.63 | ||||||
Lacticaseibacillus paracasei | 4 | 1.63 | ||||||
Enterococcus gallinarum | 4 | 1.63 | ||||||
Enterococcus faecium | 3 | 1.22 | ||||||
Lentilactobacillus buchneri | 3 | 1.22 | ||||||
Loigolactobacillus coryniformis | 3 | 1.22 | ||||||
Bacteroides kribbi | 3 | 1.22 | ||||||
Enterococcus thailandicus | 3 | 1.22 | ||||||
[Clostridium] innocuum | 3 | 1.22 | ||||||
Clostridium tertium | 2 | 0.81 | ||||||
Cutibacterium avidum | 2 | 0.81 | ||||||
Bacteroides fragilis | 2 | 0.81 | ||||||
Enterococcus hulanensis | 2 | 0.81 | ||||||
[Clostridium] symbiosum | 2 | 0.81 | ||||||
Lacticaseibacillus rhamnosus | 2 | 0.81 | ||||||
Bittarella massiliensis | 2 | 0.81 | ||||||
Blautia producta | 2 | 0.81 | ||||||
Peptoniphilus tyrrelliae | 2 | 0.81 | ||||||
Phocaeicola dorei | 1 | 0.41 | ||||||
Klebsiella oxytoca | 1 | 0.41 | ||||||
Enterococcus raffinosus | 1 | 0.41 | ||||||
Parabacteroides merdae | 1 | 0.41 | ||||||
Eggerthella lenta | 1 | 0.41 | ||||||
Eubacterium callanderi | 1 | 0.41 | ||||||
Bacteroides nordii | 1 | 0.41 | ||||||
Flavonifractor plautii | 1 | 0.41 | ||||||
Streptococcus anginosus | 1 | 0.41 | ||||||
Citrobacter braakii | 1 | 0.41 | ||||||
Totals to | 246 | 1 | Totals to | 327 | 1 | Totals to | 71 | 1 |
As shown in table 9, the experimental group had 47 isolated culturable strain species, and the control group 1 had only 14 and the control group 2 had 10. The culture medium of the experimental group can effectively reduce dominant species in the fecal sample on the separation plateEnterococcus durans(enterococcus tenaciosus),Paraclostridium dentum、 Shigella dysenteriae(shigella dysenteriae),Enterococcus faeciumThe ratio of species such as (enterococcus faecium) is reduced by about 10 percent. The experimental group had 33 more species than the control group of culturable strains isolated with a smaller colony count. Adding the same amount of CuSO 4 A similar effect cannot be achieved. To sum up, 160 mg/L CuCl is added 2 The improved YCFA culture medium of (2) can effectively improve the diversity of the culturable microorganisms in the fecal sample.
Claims (7)
1. A method for improving the diversity of fecal sample picking bacteria, comprising:
(1) Sample processing;
(2) Enrichment culture;
(3) Separating bacterial colonies;
the enrichment medium of step (2), comprising per 1L of medium the following components: 16.5-20.3 g YCFA synthetic culture medium, 0.9-1.1 g cysteine salt, 9-11 mL TE141, 2.9-3.5 mL VFA-mix, characterized in that CuCl is added into the enrichment culture medium 2 Or a hydrate thereof, in CuCl 2 The content of the composition is 140-180 mg/L.
2.CuCl 2 Or a hydrate thereof, in the preparation of an enrichment medium for increasing the diversity of the stool sample, each 1L of medium comprising the following components: 16.5-20.3 g YCFA synthetic culture medium, 0.9-1.1 g cysteine salt, 9-11 mL TE141, 2.9-3.5 mL VFA-mix, characterized in that CuCl is added into the enrichment culture medium 2 Or a hydrate thereof, in CuCl 2 The content of the composition is 140-180 mg/L.
3. An enrichment medium for improving the diversity of fecal sample picking bacteria, wherein each 1L of medium comprises the following components: 16.5-20.3 g YCFA synthetic culture medium, 0.9-1.1 g cysteine salt, 9-11 mL TE141, 2.9-3.5 mL VFA-mix, characterized in that CuCl is added into the enrichment culture medium 2 Or a hydrate thereof, in CuCl 2 The content of the composition is 140-180 mg/L.
4. The method according to claim 1 or the use according to claim 2 or the enrichment medium according to claim 3, characterized in that the step of reducing the concentration of the enriched medium is performed in CuCl 2 Counting, adding CuCl into the enrichment medium 2 Or its hydrate content is 160 mg/L.
5. The method or use or enrichment medium according to claim 4, wherein the enrichment medium reduces the separation ratio of pathogenic and/or opportunistic pathogens in a fecal sample.
6. The method or use or enrichment medium according to claim 4, wherein the enrichment medium reduces the amount of enterococcus tenuiosus selected from the group consisting of enterococcus tenuiosus in a fecal sampleEnterococcus durans)、Paraclostridium dentumBacillus dysenteriaeShigella dysenteriae) Enterococcus faeciumEnterococcus faecium) The separation duty cycle of any one of the species.
7. The method or use or enrichment medium according to claim 4, wherein each 1L of medium comprises the following components: 18.44 g YCFA synthetic medium, 160 mg CuCl 2 1 g cysteine salt, 10 mL TE141, 3.2 mL VFA-mix.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311197586.0A CN116948939B (en) | 2023-09-18 | 2023-09-18 | Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311197586.0A CN116948939B (en) | 2023-09-18 | 2023-09-18 | Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116948939A true CN116948939A (en) | 2023-10-27 |
CN116948939B CN116948939B (en) | 2023-12-12 |
Family
ID=88449551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311197586.0A Active CN116948939B (en) | 2023-09-18 | 2023-09-18 | Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116948939B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1369488A1 (en) * | 2002-06-07 | 2003-12-10 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Medium for the fermentive production of 1,3-propanediol, process and microorganism |
US20110118177A1 (en) * | 2008-06-13 | 2011-05-19 | Westfalische Wilhelms-Universitat Munster | Biotechnological production of cyanophycin dipeptides |
CN104388376A (en) * | 2014-11-07 | 2015-03-04 | 河南省烟草公司漯河市公司 | Nicotine-decomposing microorganism selective medium and preparation method thereof |
US20160230177A1 (en) * | 2013-09-17 | 2016-08-11 | Ellen M. Brune | E. coli separatome-based protein expression and purification platform |
CN107541535A (en) * | 2016-06-23 | 2018-01-05 | 上海医药工业研究院 | Fermentation medium and the method for producing Epi-ADM |
CN107815428A (en) * | 2017-11-14 | 2018-03-20 | 四川农业大学 | One plant of cadmium removes rhizobium KG2, microbial inoculum containing the rhizobium and application thereof |
CN112553118A (en) * | 2020-12-24 | 2021-03-26 | 上海理工大学 | Method for enriching beneficial bacteria by using prebiotics |
CN113699058A (en) * | 2021-07-19 | 2021-11-26 | 华东师范大学 | Salt-tolerant heat-resistant ammonia oxidizing bacteria and separation method and application thereof |
CN115261271A (en) * | 2022-08-01 | 2022-11-01 | 厦门承葛生物科技有限公司 | High-flux isolated culture and screening method for intestinal flora |
CN115969888A (en) * | 2022-10-25 | 2023-04-18 | 深圳未知君生物科技有限公司 | Saliva combined lactobacillus and application thereof in preparation of medicine for treating cancer |
CN116497083A (en) * | 2023-03-21 | 2023-07-28 | 上海承葛医药科技有限公司 | Membrane enrichment screening method for intestinal low-abundance strain |
-
2023
- 2023-09-18 CN CN202311197586.0A patent/CN116948939B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1369488A1 (en) * | 2002-06-07 | 2003-12-10 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Medium for the fermentive production of 1,3-propanediol, process and microorganism |
US20110118177A1 (en) * | 2008-06-13 | 2011-05-19 | Westfalische Wilhelms-Universitat Munster | Biotechnological production of cyanophycin dipeptides |
US20160230177A1 (en) * | 2013-09-17 | 2016-08-11 | Ellen M. Brune | E. coli separatome-based protein expression and purification platform |
CN104388376A (en) * | 2014-11-07 | 2015-03-04 | 河南省烟草公司漯河市公司 | Nicotine-decomposing microorganism selective medium and preparation method thereof |
CN107541535A (en) * | 2016-06-23 | 2018-01-05 | 上海医药工业研究院 | Fermentation medium and the method for producing Epi-ADM |
CN107815428A (en) * | 2017-11-14 | 2018-03-20 | 四川农业大学 | One plant of cadmium removes rhizobium KG2, microbial inoculum containing the rhizobium and application thereof |
CN112553118A (en) * | 2020-12-24 | 2021-03-26 | 上海理工大学 | Method for enriching beneficial bacteria by using prebiotics |
CN113699058A (en) * | 2021-07-19 | 2021-11-26 | 华东师范大学 | Salt-tolerant heat-resistant ammonia oxidizing bacteria and separation method and application thereof |
CN115261271A (en) * | 2022-08-01 | 2022-11-01 | 厦门承葛生物科技有限公司 | High-flux isolated culture and screening method for intestinal flora |
CN115969888A (en) * | 2022-10-25 | 2023-04-18 | 深圳未知君生物科技有限公司 | Saliva combined lactobacillus and application thereof in preparation of medicine for treating cancer |
CN116497083A (en) * | 2023-03-21 | 2023-07-28 | 上海承葛医药科技有限公司 | Membrane enrichment screening method for intestinal low-abundance strain |
Non-Patent Citations (5)
Title |
---|
ANUP PAUL等: "Intracellular detection of Cu(2+) and S(2+) ions through a quinazoline functionalized benzimidazole-based new fluorogenic differential chemosensor", 《DALTON TRANS》, vol. 44, no. 38, pages 16953 - 16964 * |
J A RICHAU等: "Emergence of Cu(++)-tolerant mutants defective in gellan synthesis in Cu(++)-stressed cultures of Sphingomonas paucimobilis", 《RES MICROBIOL》, vol. 148, no. 3, pages 251 - 261, XP026375459 * |
WANG, Q等: "kinetics and equilibrium properties of the bio sorption of Cu2+ by algae", 《ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH》, vol. 19, no. 9, pages 3889 - 3894 * |
张娅婷等: "沼泽红假单胞菌的分离鉴定及对重金属铜的响应的研究", 《河南科学》, vol. 29, no. 11, pages 1322 - 1326 * |
李艳梅等: "镍胁迫下产铁载体细菌对花生的促生性", 《微生物学通报》, vol. 33, no. 08, pages 1882 - 1890 * |
Also Published As
Publication number | Publication date |
---|---|
CN116948939B (en) | 2023-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104342390A (en) | Sinorhizobium meliloti strain and composition and application of sinorhizobium meliloti strain | |
CN105950712A (en) | System for identification or assisted identification of microorganisms in beer production process and application thereof | |
CN101993841A (en) | Xanthomonas sp.SN-58 and method for preparing xanthan gum by using xanthomonas sp.SN-58 | |
CN111004753A (en) | Lactobacillus paracasei capable of highly producing selenocysteine and application thereof | |
CN106434483A (en) | Lactobacillus buchneri and application thereof | |
CN107034157A (en) | A kind of Lactobacillus plantarum and its application | |
CN116948939B (en) | Method for improving bacterial diversity of fecal sample, culture medium and application of culture medium | |
CN115895974B (en) | Lactobacillus plantarum rich in selenium and high in gamma-aminobutyric acid yield and application thereof | |
CN101921712B (en) | Yeast stain for producing astaxanthin and glutathione by fermentation method and production process thereof | |
CN109423466A (en) | A kind of composite fermentation microbial inoculum and its application | |
CN113174343B (en) | Microbial flora for producing lactic acid by utilizing lignocellulose and fermentation method | |
CN108148763A (en) | A kind of method that the very thin Euglena yield of shake flask fermentation is improved by feeding method | |
CN111100802B (en) | Enterococcus faecalis and application thereof | |
CN104371950B (en) | Oxygen resistant clostridium and application of oxygen resistant clostridium in aerobic synthesis of O-desmethylangolensin | |
CN102321553A (en) | Feather keratin anaerobic degradation strain 18D-TA | |
KR20110101868A (en) | Lactobacillus kimchicus dcy51 | |
CN116676212B (en) | Brevibacillus aydinogluensis PMBT001 strain and application thereof | |
CN116574644B (en) | Parageobacillus toebii PMBT002 strain and application thereof | |
CN108624626A (en) | A kind of bacterial strain and method producing bata-phenethyl alcohol | |
CN113215064B (en) | Slime bacterium for producing meishadazole compounds and application thereof | |
CN114231461B (en) | Clostridium butyricum, composition and application thereof, and fermentation culture method of clostridium butyricum | |
CN114480146B (en) | Application of aspergillus oryzae strain in copper, iron, manganese and zinc enrichment | |
CN115386525B (en) | Bacillus subtilis, microbial inoculum, application and method for preparing tetramethylpyrazine | |
CN116004470B (en) | Helicobacter sulfide SG202 and application thereof | |
CN116814509B (en) | Ethanol-resistant, acid-resistant and high-acid-yield acetobacter pasteurii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |